Joseph Joe Lukose Vadakara MD FACP

Oncology•Danville, PA

Hematologic Oncology

Geisinger Hematology Oncology

Join to View Full Profile

100 N Academy AveDanville, PA 17822
Phone+1 570-271-6045
Fax+1 570-271-6542

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Drexel University College of Medicine/Hahnemann University HospitalChief Residency, Internal Medicine, 2009 - 2010
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2006 - 2009
University of Kerala Medical CollegeClass of 2004

Certifications & Licensure

PA State Medical License 2006 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma Start of enrollment: 2010 Sep 01
Completed
Phase 2
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
ACTIVE_NOT_RECRUITING
PHASE3
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma Start of enrollment: 2012 Sep 01
Active, not recruiting
Phase 2
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
ACTIVE_NOT_RECRUITING
PHASE3
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma Start of enrollment: 2015 Sep 08
ACTIVE_NOT_RECRUITING
PHASE3
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Aug 27
Completed
Phase 2
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2016 Oct 12
ACTIVE_NOT_RECRUITING
PHASE3
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Start of enrollment: 2015 Aug 17
ACTIVE_NOT_RECRUITING
PHASE2
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery Start of enrollment: 2015 Aug 13
Completed
Phase 2
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery Start of enrollment: 2015 Nov 10
ACTIVE_NOT_RECRUITING
PHASE3
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Start of enrollment: 2015 Dec 01
Active, not recruiting
Phase 3
The National Myelodysplastic Syndromes (MDS) Study Start of enrollment: 2016 Jun 13
ACTIVE_NOT_RECRUITING
Join now to see all

Publications & Presentations

PubMed

Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.
Anand P Jillella, Sandra J Lee, Jessica K Altman, Selina M Luger, Martin S Tallman
JAMA Oncology. 2025-02-27
3 citations
Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and Thyroid Cancer Treated With VEGFR TKIs.
Vivek Narayan, Tao Liu, Yunjie Song, Joshua Mitchell, JoRean Sicks
Journal of the National Comprehensive Cancer Network. 2023-10-01
1 citations
Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the Spleen.
Kathie Wu, Joseph Vadakara
Cureus. 2023-03-01

Press Mentions

Help Desk for Oncologists Treating People with a Rare Leukemia Pays Big DividendsFebruary 2nd, 2023

Professional Memberships

American College of Physicians - ACP
Fellow
American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American Society for Blood and Marrow Transplantation-ASBMT
Member